Please use a PC Browser to access Register-Tadawul
Get It
Allarity Therapeutics Doses the First Patients With Stenoparib And Temozolomide In VA-Funded Investigator-Initiated Phase 2 Trial For Relapsed Small Cell Lung Cancer
Allarity Therapeutics, Inc. ALLR | 1.24 | +21.57% |
